ST. CLOUD, Minn. – June 23, 2026 – CentraCare Heart & Vascular recently shared a major clinical milestone on LinkedIn, announcing their program as the first in the Midwest to successfully enroll a patient in the SUPPORT II clinical trial evaluating the investigational Supira System.

A LinkedIn post from CentraCare announcing their program as the first in the Midwest to successfully enroll a patient in the SUPPORT II clinical trial. The post details how the temporary heart pump allows a patient's heart to rest and recover during complex procedures, and features a photo of the clinical research team posing together in the hospital corridor holding a sign.